Printer Friendly

Articles from BIOTECH Patent News (November 1, 2004)

1-26 out of 26 article(s)
Title Author Type Words
Adisseo obtains United States patent. Brief Article 110
Ajinomoto obtains United States patent. Brief Article 97
BASF obtains United States patent. Brief Article 90
Bayer obtains United States patent. Brief Article 97
Bionomic's gene silencing molecules inhibitor tumor growth in breast cancer model. 397
Bionomics and GTG announce strategic alliance to jointly commercialise new genetic tests for epilepsy. 413
Bionomics commercialization gaining momentum. 619
BioteCon obtains United States patent. Brief Article 170
Boston Biomedical Research Institute and Wyeth announce licensing of Alzheimer's immunotherapy technology. 398
Chiron obtains United States patent. 108
Competitive licenses homocysteine assay to Diagnostic Products. 615
Drug development program further strengthened with issuance of a new patent. 579
Eiffel signs lucrative asthma development agreement. 562
Fraunhofer obtains United States patent. Brief Article 143
Gedeon Richter and Forest collaborate on atypical antipsychotic for schizophrenia, bipolar mania and other psychiatric disorders. 1098
Human Genome Sciences obtains United States patent. Brief Article 159
Nanogen issued patent for device that combines optical waveguides and molecular diagnostics. 349
Nastech acquires exclusive worldwide rights to peptide YY analog patents and patent applications from University of Cincinnati. 834
OxyPharma files patent application for substances for the treatment of rheumatoid arthritis and multiple sclerosis. Brief Article 308
Palatin Technologies expands patent portfolio in the treatment of sexual dysfunction. 782
Rutgers obtains United States patent. Brief Article 132
SemBioSys receives United States patent for vaccine production technology. 318
Topigen obtains United States patent. Brief Article 109
TransMolecular broadens patent portfolio for lead oncology products with fifth issued United States patent. Brief Article 281
USPTO to re-examine CNS' nasal strip patents. Brief Article 242
XenoPort issued United States composition of matter patent covering gabapentin prodrug. 427

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters